This is the second article in a six-part series exploring critical themes shaping the future of functional mushrooms, in partnership with Finnish biotech company KÄÄPÄ Biotech . In the evolving landscape of the functional mushroom industry, transparency has emerged as a cornerstone of consumer trust, product integrity, and scientific credibility. As the functional mushroom market rapidly grows ( see the first article in this series by KÄÄPÄ Biotech ), together with the trendi

White Paper, Beyond Beta-Glucans, builds on years of scientific development to propose a compelling, evidence-based rethink. It’s time the industry moves beyond beta-glucan content as the default quality metric.

Researchers examined four wild mushroom species from Kargil and found them packed with essential nutrients, antioxidants, and bioactive compounds, positioning them as promising candidates for dietary supplements and functional foods.

As mycelium-based innovation moves into mainstream health and nutrition, this research is a reminder that not all mycelium is equal. Chaga is just the case study—but it’s a revealing one.

Article written in partnership with Mabel   a Paris-based company producing functional mushroom and microdosing supplements. Read more on...